Intravenous immunoglobulin in pregnancies complicated by the antiphospholipid syndrome: What is its role?

Journal of Clinical Rheumatology

Volumn 7, Issue 5, 2001, Pages 291-294

  Carp, H J A ^a   Asherson, R A ^a   Shoenfeld, Y ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; ENOXAPARIN; HEPARIN; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY;

ABORTION; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EDITORIAL; HUMAN; META ANALYSIS; PATHOGENESIS; PLASMAPHERESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0034755498     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200110000-00007     Document Type: Editorial

References (41)

1. Antiphospholipid antibodies - Lobsters or red herrings
2. Obstetric complications associated with the lupus anticoagulant
3. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast
4. Recurrent miscarriage: Autoimmune considerations
5. A study of sixty pregnancies in patients with the antiphospholipid syndrome
6. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies
7. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)
8. Treatment of patients with antiphospholipid antibodies during pregnancy
9. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone to low dose heparin treatment
10. Antiphospholipid antibody syndrome and pregnancy
11. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
12. The epidemiology of human spontaneous abortions with chromosomal anomalies
13. Cytogenetic study of spontaneous abortions by transabdominal villus aampling and direct analysis of villi
14. Frequency of abnormal karyotype among abortuses from women with and without a history of recurrent spontaneous abortion
15. Embryonic karyotype of abortuses in relation to the number of previous miscarriages
16. Karyotype of the abortus in recurrent miscarriage
17. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies
18. Paternal leukocyte immunization and habitual abortion
19. Lupus anticoagulant: Significance in first trimester habitual abortion
20. Increased fetal loss in women with heritable thrombophilia
21. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses
22. Antiidiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use
23. In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by anti-idiotypic mechanisms
24. Intravenous immunoglobulin therapy of antiphospholipid syndrome
25. The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome
26. Lupus antocoagulant and recurrent pregnancy fetal loss: Successful treatment with gammaglobulin
27. Antiphospholipid antibodies and recurrent pregnancy loss
28. A comparison of pregnancy outcome after two treatments for antibodies to cardiolipin (ACA)
29. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization
30. Intravenous gamma globulin, antiphospholipid antibodies and pregnancy
31. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions
32. Intravenous immunoglobulin treatment of women with multiple miscarriages
33. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy
34. Pregnancy complicated by the antiphospholipid syndrome: Outcomes with intravenous immunoglobulin therapy
35. Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: A pilot study of treatment with intravenous immunoglobulin
36. Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: A comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin
37. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy
38. Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: A review
39. Normal fetal growth in women with antiphospholipid syndrome treated with high dose intravenous immunoglobulin (IVIg)
40. Intravenous immunoglobulin infusion therapy in women with recurrent spontaneous abortions of immune etiologies